HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sotaro Ooto Selected Research

Macular Edema

3/2024Foveal Thickness Fluctuations in Anti-VEGF Treatment for Central Retinal Vein Occlusion.
11/2022MACULAR BLOOD FLOW CHANGES IN BRANCH RETINAL VEIN OCCLUSION EXAMINED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VARIABLE INTERSCAN TIME ANALYSIS.
1/2022Foveal Thickness Fluctuation in Anti-VEGF Treatment for Branch Retinal Vein Occlusion: A Long-term Study.
6/2021NONPERFUSION AREA QUANTIFICATION IN BRANCH RETINAL VEIN OCCLUSION: A Widefield Optical Coherence Tomography Angiography Study.
11/2020Factors associated with extremely poor visual outcomes in patients with central retinal vein occlusion.
10/2019FIXATION STATUS AFTER RESOLUTION OF MACULAR EDEMA ASSOCIATED WITH BRANCH RETINAL VEIN OCCLUSION.
1/2019Branch Retinal Vein Occlusion: Treatment Outcomes According to the Retinal Nonperfusion Area, Clinical Subtype, and Crossing Pattern.
2/2018EVALUATION OF MACULAR ISCHEMIA IN EYES WITH BRANCH RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
1/2018EVALUATION OF MACULAR ISCHEMIA IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
1/2018Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sotaro Ooto Research Topics

Disease

36Macular Degeneration (Age-Related Maculopathy)
01/2024 - 07/2011
20Polypoidal Choroidal Vasculopathy
01/2024 - 07/2010
17Macular Edema
03/2024 - 03/2010
16Retinal Vein Occlusion
03/2024 - 06/2014
12Atrophy
11/2023 - 01/2013
11Choroidal Neovascularization
09/2023 - 12/2004
9Hemorrhage
02/2024 - 02/2010
7Retinal Perforations
11/2023 - 07/2010
6Central Serous Chorioretinopathy
06/2022 - 05/2010
5Epiretinal Membrane (Epiretinal Membranes)
01/2024 - 05/2011
5Myopia
11/2023 - 01/2012
5Glaucoma
09/2020 - 06/2012
3Vitreous Hemorrhage
02/2024 - 01/2012
3Retinal Arterial Macroaneurysm
11/2023 - 09/2021
3Retinal Detachment (Retinal Detachments)
01/2022 - 07/2012
3Ganglion Cysts (Ganglion)
12/2018 - 11/2011
3Retinitis Pigmentosa (Pigmentary Retinopathy)
06/2017 - 01/2013
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2015 - 01/2010
3Telangiectasis (Telangiectasia)
06/2013 - 07/2011
2Vision Disorders (Hemeralopia)
01/2024 - 05/2011
2Bietti Crystalline Dystrophy
06/2017 - 01/2016
2Geographic Atrophy
01/2016 - 02/2013
2Disease Progression
04/2013 - 02/2010
2Angioid Streaks
04/2013 - 06/2012
1Vascular Diseases (Vascular Disease)
02/2024
1Infections
07/2022
1COVID-19
07/2022
1Vitreous Detachment (Posterior Vitreous Detachment)
01/2022
1Giant Cell Arteritis (Horton Disease)
10/2021
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
10/2021
1Neoplasms (Cancer)
10/2021
1Colitis
10/2021
1Aplastic Anemia (Anemia, Hypoplastic)
10/2021
1Polyps
01/2021
1Open-Angle Glaucoma (Glaucoma, Open Angle)
09/2020
1Sclerosis
08/2019
1Retinal Hemorrhage
01/2016
1Cysts
04/2015
1Retinal Diseases
02/2015
1Contracture
01/2015
1Fundus Albipunctatus
03/2014
1Acute zonal occult outer retinopathy
03/2013
1Hamartoma
01/2013
1Malignant Hypertension
08/2012
1Papilledema
07/2012
1Inflammation (Inflammations)
03/2010
1Endophthalmitis (Ophthalmia)
03/2010
1Retinal Degeneration
04/2007

Drug/Important Bio-Agent (IBA)

46Retinaldehyde (Retinal)IBA
02/2024 - 04/2007
22Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2024 - 06/2012
20Ranibizumab (Lucentis)FDA Link
11/2023 - 01/2012
16afliberceptIBA
11/2023 - 11/2014
101-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2023 - 02/2010
8N-acetyltryptophanamide (NATA)IBA
03/2024 - 04/2017
6Bevacizumab (Avastin)FDA Link
01/2015 - 03/2010
5Fluorescein (Funduscein)FDA LinkGeneric
06/2021 - 01/2013
5Retinal Pigments (Pigments, Visual)IBA
01/2018 - 01/2013
5Indocyanine Green (Cardio-Green)FDA LinkGeneric
04/2013 - 05/2010
3Complement Factor H (Factor H)IBA
11/2019 - 06/2012
3FibrinIBA
08/2012 - 08/2010
2faricimabIBA
01/2024 - 11/2023
2Prednisolone (Predate)FDA LinkGeneric
07/2022 - 10/2021
2Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
04/2013 - 07/2010
1Vascular Endothelial Growth FactorsIBA
11/2023
1Therapeutic UsesIBA
11/2023
1AngiopoietinsIBA
11/2023
1Tissue Plasminogen Activator (Alteplase)FDA Link
11/2023
1Verteporfin (Visudyne)FDA Link
06/2022
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2021
1Mesalamine (Mesalazine)FDA LinkGeneric
10/2021
1Pregnenolone Carbonitrile (PCN)IBA
11/2020
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
11/2019
1N 30IBA
08/2019
1SDDSIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
10/2017
1pigment epithelium-derived factorIBA
07/2011
1LipidsIBA
03/2011
1Anti-Bacterial Agents (Antibiotics)IBA
03/2010
1SteroidsIBA
03/2010
1Sulfur HexafluorideIBA
02/2010
1Estrogens (Estrogen)FDA Link
12/2004
1Estrogen ReceptorsIBA
12/2004

Therapy/Procedure

17Lasers (Laser)
09/2020 - 09/2010
13Injections
01/2024 - 01/2012
13Intravitreal Injections
12/2021 - 03/2010
12Photochemotherapy (Photodynamic Therapy)
01/2023 - 02/2010
12Therapeutics
06/2022 - 04/2013
6Traction
02/2024 - 04/2015
5Vitrectomy
11/2023 - 03/2010
5Aftercare (After-Treatment)
03/2022 - 07/2012
1Retreatment
07/2011